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From the
President

"Skill in the art of
communication is crucial to a leader's
success. He can accomplish nothing unless
he can communicate effectively."
- Norman Allen
Colleagues:
At the General Medical Staff meeting on
December 13, I announced that beginning
January 1, 2000 all announcements from the
medical staff office will be sent to members
of the combined medical staff via e-mail. We
will also send the same announcements to
members of the staff via the usual printed
format. Our plan will be to continue the dual
proces$ of delivering e-mail and printed
announcements for the next year. On
January 1, 2001, all medical staff
announcements will only be sent via e-mail.
I would encourage all members of the staff
to begin to read their e-mail regularly. If you
can't bring yourselves to do this, please
appoint a member of your staff to serve as
your e-mail surrogate to read and print out
your e-mail for you. We are entering the
new millennium. This is the age of
information. The hospital has just converted
to an upgraded and more powerful network
with new network software and "single signon" capability. I'm sure that most of you are
already using the Internet from either your
homes or offices. We will be receiving more
and more of our information electronically. It
is time for the medical staff of the Lehigh
Valley Hospital/Muhlenberg Hospital Center
to enter the "electronic age." This is a
simple first step. I would encourage you to
try the process and see if you think e-mail
will help in your daily practice and perhaps
even improve clinical communication
between members of the medical staff.
(Continued on Page 2)
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We all now have the new "GUI" (Graphical User Interface) email system. This allows us to attach documents to e-mail
messages. We can send information to our colleagues directly
about patients and attach office notes typed on any word
processing program. I believe that this will be an expeditious
way to improve the flow of clinical information between
members of the medical staff.
Also at the General Medical Staff meeting, Dr. Robert
Laskowski made an excellent presentation about the
importance of the activities of the Care Management Council
directed to influencing our practice in the care of hospitalized
patients. Bob pointed out how the monies generated through
"operations improvement" provide the capital to invest in new
equipment and programs for the care of our patients in the
future. Without these funds we will be forced to "live with what
we have."
As an example, Bob pointed out the commitment that the
members of the vascular surgery division have made to
operations improvement. They are very anxious to have the
hospital purchase the equipment, which they need for the
development of the capability to perform endovascular surgical
procedures. The funds for this equipment will become
available through their commitment and efforts to shorten
length-of-stay for many of their patients with complicated lower
extremity vascular disease. Without similar commitments by
many members of the medical staff, funds to make capital
investments in new equipment and programs will simply not be
available.
Bob and John Jaffe, as co-chairs of the Care Management
Council, have stressed the importance of "length-of-stay"
reductions for our hospitalized patients as the "engine" which
will generate the funds for capital investment. I know that
many of you are growing weary of my preaching about "lengthof-stay." Perhaps we should be thinking more about what we
are doing for our patients in the hospital and whether the
patients' conditions justify a continued stay in a hospital
environment. "lnterQual" criteria take into account the severity
of the patient's condition, and the need for inpatient service.
Dr. Keith Doram, our chief of General Internal Medicine, has
pointed out the utility of these guidelines in deciding whether
patients need to remain in the hospital. Could what we are
doing for our patients today in the hospital be done just as
well, at less cost, and with more comfort for the patients in
some setting other than the hospital?
Many of my surgical colleagues schedule their patients for
elective surgical procedures and know approximately how long
the patient will need to remain in the hospital for that
procedure. Most of our "medical" patients and many surgical
patients are not scheduled electively, but are admitted with an
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acute medical or surgical problem. I would encourage the
attending physicians to begin to consider the expected "lengthof-stay" for all patients upon their admission.
~

~

How long do I think this patient will need to be hospitalized
for this problem?
What discharge plans do I need to consider on admission
so that the patient and family will be ready for the
patient's discharge on the expected date?

Patients, families, and caregivers should be educated as to
this expected date of discharge and what they will need to do
to prepare for the discharge. The hospital's Clinical Case
Managers can obviously help to see that the appropriate plans
for hospital discharge and post hospital care are formulated.
In this age of radical cost pressures on the hospital, we do,
unfortunately, need to pay attention to the "length-of-stay" of
our patients. As much as physicians hate to think that our
patients' care is being regulated and "rationed" by the
economics of the present health care reimbursement system,
we do need to pay attention to these issues. The survival of
the hospital and its ability to provide capital resources for new
equipment and programs depends on the availability of funds
which can only be generated by us working with the hospital to
develop more efficient ways to care for our patients.
Most of us have already heard something about the Institute of
Medicine Report of November 29, 1999. Issued by the Quality
of Health Care in America Committee, this report -- To Err is
Human: Building a Safer Health System -- is available on
the Internet at http://www4.nationalacademies.org/news.nsf.
Although it may be possible to direct some criticism at the
methods employed to develop this report, the issues raised by
the report deserve our attention and thoughtful consideration.
Is our health care system unsafe? Is the current health care
system in which we work fraught with errors that are frequently
harmful or lethal to the patients whose lives we are committed
to improving?
We need to consider the things we do each day in the hospital,
which have the potential to result in errors and harm to our
patients. One of these is the very common problem, which is
shared by many physicians (including myselij, of handwriting
which is difficult to read or even illegible. Notes and orders
that we write in patients' charts which are difficult for the
nursing and secretarial staffs to read create the potential for
untoward events occurring to our patients. The nursing and
secretarial staffs, in trying to decipher these illegible orders,
waste considerable time. This time could be more productively
devoted to patient care. Incorrect dosages of medication or
even the administration of unintended medications to our
patients can occur as a result of our haste in writing orders,
which are confusing or illegible.
(Continued on Page 3)
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One suggestion has been for physicians to print their names
and pager number after their signature when writing orders or
progress notes. If the nursing staff has difficulty interpreting an
order, they can then easily identify the physician who wrote the
order so that the confusion may be quickly clarified. There
was a discussion of this suggestion at the December Medical
Executive Committee meeting. I believe that for those of us
who have trouble writing clearly the suggestion to follow written
orders with a printed name and pager number makes sense
and is a simple way to try to reduce errors.
I point out that The Bylaws of the Common Medical Staff of
the Lehigh Valley Hospital and Muhlenberg Hospital
Center have specific language dealing with the legibility of the
inpatient medical record:
"All orders and progress notes written on the chart
shall be dated. Timed documentation is encouraged.
All orders must be written clearly, legibly and
completely. Orders which are illegible or
improperly written will not be carried out until
rewritten or understood by the nurse. Any
practitioner with non-legible handwriting will be
required to print or stamp his or her full name
under his or her signature." 1 (My emphasis).
I also believe that the use of a computerized physician order
entry system would further help to reduce errors in the
hospital. Some of us have seen such a system in operation in
Boston. The experience there has been that a significant
reduction has occurred in the number of errors related to the
dispensing and delivery of medications to hospitalized patients.
I believe that the hospital administration and interested
physicians need to study the possibility of implementing such a
system. I'm sure that in the future all of us will be using some
type of computerized order entry system in our practice in the
hospital.
Sit, Answer and Touch!
Remember, when you are making hospital rounds to sit at your
patient's bedside, ask for their questions, answer their
questions, and make physical contact with the patient.
Members of the medical and nursing staffs have informed me
that many of the inpatient nursing units at the LVH do not have
Physician's Desk References available for use. Many of
1
The Bylaws of the Common Medical Staff of the Lehigh
Valley Hospital and Muhlenberg Hospital Center.
September 8, 1999. Part II, MEDICAL STAFF RULES AND
REGULATIONS, E. Records, #11. Page 84.
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these volumes have disappeared over time. I would
encourage members of the medical staff who have used 1999
editions of the PDR to bring them to the Medical Staff Office so
that they can be distributed to the nursing units which currently
do not have access to this useful volume. I'd remind the
physicians on the staff that we all have Micromedex available
at all of the computer workstations for reference regarding
medications.
E-MAIL
Once again, I'd like to encourage all members of the Medical
Staff to read their e-mail regularly or to designate a staff
member to be your appointed a "surrogate", who can read and
print out your e-mail messages for you on a daily basis. If you
or your staff need help in assigning a "surrogate," please call
Information Services at (61 0) 402-8303, then press "1."
I hope that the above "communication" has provided some
thought provoking information for the Medical Staff to ponder
over the next month. Finally, I'd like to wish all of my
colleagues on the Medical Staff a very safe and Happy New
Year.

David M. Caccese, MD
President, Medical Staff
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Influenza A has Arrived!

COPD and CAP Guidelines

Please take note of the following points for assistance in the
management of suspected and confirmed Influenza A patients
in the hospital environment.

Clinical pathways/guidelines have been developed for patients
admitted to Lehigh Valley Hospital at Cedar Crest & 1-78 with
COPD or with Community Acquired Pneumonia (CAP). Input
from representatives of several key areas within the hospital
was obtained, including Family Practice, General Internal
Medicine, Pulmonary Medicine, Infectious Diseases, Nursing,
Respiratory Therapy, Pharmacy, and Care Management. It is
hoped that the use of these guidelines will result in improved
clinical outcomes and more cost efficient care. In order to
facilitate the use of these guidelines and to promote physician
awareness and utilization, pre-printed admission orders have
been generated for both of these diagnoses. These orders are
meant to facilitate the admission process for physicians
admitting patients with COPD or CAP. Of course, addition to
or subtraction from these orders, at the discretion of admitting
physicians, are encouraged to maximize any individual
patient's care. Pre-printed admission order sheets and copies
of the pathways are now available on all of the nursing units
and in the Emergency Department at Cedar Crest &1-78.

);>

If you Strongly Suspect or Know a patient has Influenza
infection, place the patient in Droplet Isolation (private
room, mask when within 3 feet of patient).

);>

Suspected cases can be confirmed by viral culture or
made clinically (high fever, severe myalgia, multiple
cases, short (three day) incubation). Health Network
Laboratories offer a Rapid Influenza A Screen test. If the
rapid screen is negative, cultures will automatically be set
up for an Influenza AlB Culture Screen. Viral culture kits
are available through Health Network Laboratories by
calling (610) 402-8170. A doctor's order for Influenza
Culture should suffice.

);>

Rimantadine (Fiumadine®) at 100 mg twice a day is
helpful for prevention or therapy for Influenza Type A.
Modify dosage to 100 mg once a day for renal
insufficiency and age 65 years and above.

);>

);>

Infection Control will notify the physicians of roommates
of patients identified with influenza to alert them to the
potential exposure. In these instances, it is recommended
the physician inquire about vaccination history and then
watch for flu - like symptoms in unvaccinated patients.
Patients vaccinated for influenza post exposure should be
continued on rimantadine for 14 days allowing for the
vaccine to take effect.

);>

If Influenza Type 8 becomes clinically evident, there are
two new medications for Type 8 -- oseltamivir (Tamiflu®)
and zanamivir (Relenza®) -- which you may want to
investigate.

);>

Although the optimal time for influenza vaccination is
October through mid-November, health-care providers
should continue to offer influenza vaccine up to and even
after influenza activity has been detected in the
community, particularly to those persons at high risk for
influenza-related complications.

Individuals at high risk for complications from influenza should
be placed on a yearly vaccination schedule for influenza by
their health care provider. In addition, all health care providers
should be vaccinated to reduce the risk of transmission to
patients. Any additional questions can be directed to the
Infection Control Department at (610) 402-0680.

Data will be collected on certain key outcomes, including
length of stay, to determine if these guidelines and pre-printed
orders make a difference in managing patients with COPD or
CAP. As this data becomes available, the results will be
disseminated to the medical staff and other clinical staffs.
Providing our patients with the best care possible while
attempting to be as cost efficient as possible is a top priority. It
is hoped that these pathways will help to achieve that goal.
Please utilize them for your patients with COPD and CAP.
If you have any questions or concerns regarding this issue,
please page Jay H. Kaufman, MD, Chief, Division of
Pulmonary, on beeper (610) 920-7221 or Marlene Ritter, Care
Management Department, on beeper (610) 830-7081.
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News from the Department of Care and
Resource Management

).- Facilitate new care management and operation
improvement strategies.

Currently, the Department of Care and Resource Management
performs the following functions:

).- Track outcomes associated with clinical process change.

).- Case Management
).- Quality/Performance Improvement
).- Clinical Information Analysis
Paula Stillman, MD, Senior Medical Director, Care and
Resource Management, is pleased to announce the following
changes which more accurately reflect the roles within the
Care and Resource Management Department.

Beth Karoly is the Senior Clinical Information Analyst. Her
associates include Jo Ann Gruber, Marlene Ritter and Marsha
Faden.
The goal of the Department of Care and Resource
Management is to provide one-stop shopping for your clinical
data needs. If you require clinical information to help you
provide better care for your patients or to answer a clinical
question, please call the Department of Care and Resource
Management at (610) 402-1770 or (610) 402-1760.

Case Managers, formerly known as Clinical Resource
Managers, have the following roles and responsibilities:

).- Meet with the patient and/or family on admission, or prior
to admission, to assess needs for hospital care.
).- Work with the patient/family and health care team to
formulate post-hospital care plans including transfers to
SNF, Rehab, coordination of home health, and arranging
medical equipment.
).- Communicate with insurance companies to obtain
authorization for inpatient stay as well as follow-up
services.
).- Facilitate efficient and timely care of the patient. Insure
appropriateness of setting for service.
To best meet the needs of our patients, case managers are
assigned to each inpatient care unit, as well as the Emergency
Department. They are available Monday through Friday from 8
a.m. to 4:30 p.m., and there is a case manager on call after
hours. To provide services on weekends, three case
managers are in-house at Lehigh Valley Hospital.
Susan Lawrence, Administrator of Quality and Case
Management, carries network-wide responsibilities for
Performance Improvement and Case Management. Maureen
Sawyer is the Director of Case Management at Muhlenberg
Hospital Center and the Transitional Skilled Unit.
Clinical Information Analysts, formerly known as Clinical
Process Development Coordinators, have the following roles
and responsibilities:

).- Retrieve and analyze data from a variety of databases.
).- Develop reports to allow for ongoing measurement of care
management initiatives.

Ultrasound Preliminary Reports at
Muhlenberg Hospital Center
The Ultrasound Department at Muhlenberg Hospital Center is
implementing a new way to report preliminary ultrasound
findings to the physicians on all inpatients and Emergency
Department patients. A preliminary interpretation form will be
inserted in the radiology section of the patient chart for both
positive and negative findings immediately following the exam.
With the availability of this information, the radiologists will no
longer need to call the ordering physician unless a phone call
is specifically requested at the time the order is written.
This change is being made to improve the efficiency of relaying
findings to the nursing staff and physicians. It has already
proven successful at both Cedar Crest & 1-78 and 171h & Chew.
If you have any questions regarding this issue, please contact
Janice Hickey, ROMS, lead sonographer, at (610) 861-2276.

Clinical Trial for Depression
As part of a national study, Lehigh Valley Hospital is currently
enrolling adults with symptoms of depression in a clinical trial
for an investigational drug. Enrollees receive a free
depression screening and medical evaluation. After the
screening and evaluation, if qualified, the participant will
receive the drug and study-related medical attention for one
year. There is no placebo. Participants must be medically
stable otherwise. Laurence P. Karper, MD, Medical Director,
Behavioral Health Emergency Services, is the principle
investigator for the study. For more information, call
(610) 402 -CARE.
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Good Shepherd Specialty Hospital-Allentown:
Opening Scheduled for January 17, 2000
Is the project on target with its deadlines?
Yes, six of the beds of the Good Shepherd Specialty HospitalAllentown (GSSH) will be ready to receive patients on 6C by
January 17, 2000. In mid-June, the remaining 26 beds will be
available.
How do I get privileges to practice in the Good Shepherd
Specialty Hospital-Allentown?
All Lehigh Valley Hospital physicians are welcome to join the
medical staff in order to provide continuity of care from the
hospital into the GSSH. All you need to do is stop by the
GSSH Administrative Office on the first floor of the hospital and
write your name on the application, sign a consent to access
your credentials file in the Lehigh Valley Hospital Medical Staff
Services Office, and complete the delineation of privileges
form.
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Linda Dean, Administrative Consultant, at (610) 402-8963
or pager (610) 830-3110
Nancy Hardick, Medical Staff Affairs, at (610) 402-8962

Recruiting Physicians to Your Practice
The Physician Recruiting Service of Lehigh Valley Health
Network is now available to private practices that are primarily
affiliated with Lehigh Valley Hospital or Muhlenberg Hospital
Center. With over 10 years of experience in recruiting
physicians to Lehigh Valley Hospital, the professional team of
recruiters is well prepared to assist private practices in their
recruiting needs. In fact, this group has been responsible for
recruiting over 115 members of the current medical staff of
Lehigh Valley Hospital. Physicians in a wide spectrum of
specialties and subspecialties have been recruited, from family
physicians and the Chairperson, Department of Pediatrics, to
neuropathologists and pulmonary/critical care subspecialists.

How is the programming in the Good Shepherd Specialty
Hospital-Allentown (Long Term Acute Care HospitaiLTACH) different from traditional acute care?
Each patient will receive care from a program specific
interdisciplinary team of nursing, therapy and physician
specialists. Under the direction of the three program medical
directors (pulmonary, medically complex, and rehabilitation),
additional care providers will be assigned to each patient
depending on need. These care providers include respiratory
therapists, care managers, physical, occupational, speech and
recreation therapists, and psychologists. Pastoral and
education services will be available to all patients and their
families. The team will meet formally each week to discuss
each patient's progress.

In addition to managing physician searches for Lehigh Valley
Hospital, the team has conducted searches for a number of
private practices affiliated with Lehigh Valley Health Network.
Physicians have been successfully recruited for the following
practices:

If I choose to attend my patients, what are my
responsibilities?
If you choose to attend your own patients, daily medical
management is expected. In addition, you are required to
attend a weekly team conference to discuss your patient(s)
status, goals and plans. Typically, each patient is discussed
for 5-1 0 minutes.

The Physician Recruiting Service also assists other
PennCARE hospitals in their searches and has, for example,
recruited 10 physicians for Grand View Hospital over the past
three years.

Who is available to answer questions about the Good
Shepherd Specialty Hospital-Allentown?
The following individuals can answer your questions:
~
~

~

Stephen C. Matchett, MD, GSSH Medical Director, at
(610) 439-8856 or pager (610) 920-7225
Jane Dorval, MD, GSSH Medical Staff President, at (61 0)
776-3340 or pager (61 0) 830-2793
Joseph Pitingolo, GSSH Administrator, at (61 0) 402-8559
or pager (610) 830-4389

•
•
•
•
•
•
•
•

Allentown Anesthesia Associates Inc.
Allentown Associates in Psychiatry and Psychology
Allentown Infectious Diseases Service
Health Network Laboratories
Muhlenberg Primary Care, PC
Pulmonary Associates
Urologic Associates of Allentown Inc.
Valley Gastroenterologists

Services provided by Physician Recruiting of Lehigh Valley
Health Network include finding qualified candidates, arranging
their on-site visits, and working closely with spouses and
families to promote the Lehigh Valley area. These services
are provided at a fraction of the cost typically charged by
outside search firms.
This is an excellent opportunity to use a proven service at a
reasonable cost. Physicians who are considering adding to
their practices should contact Carol G. Voorhees, Director of
Physician Recruiting, at (610) 402-7008. One of the recruiters
will come to your office to consult with you on your recruiting
plans.
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THIRD FLOOR
Labor & Delivery
Twelve birthing suites provide the "ultimate birthing
experience" in a home-like setting with massage tub, whirlpool
and cozy living room settings; 10 suites for mothers with highrisk pregnancies and access to three perinatologists.
FOURTH FLOOR
Mother & Baby Unit
After the new baby arrives, mothers and exhausted dads can
relax in one of 27 private family rooms with sleeping chairs,
seated showers and special bassinets.

Neonatal Intensive Care Unit
The most experienced NICU in the region.
Pediatric Intensive Care Unit
The Lehigh Valley's first pediatric intensive care unit in
partnership with The Children's Hospital of Philadelphia
(CHOP).

Congratulations!
Trent P. Conelias, DDS, Division of Oral and Maxillofacial
Surgery, has satisfied the requirements of the American Board
of Oral and Maxillofacial Surgery, and has become certified as
a Diplomate in the specialty of Oral and Maxillofacial Surgery.
Samuel W. Criswell, Sr., MD, Department of Family Practice,
was recently notified that he successfully completed the
Recertification Examination and has become recertified as a
Diplomate of the American Board of Family Practice.

FIRST FLOOR
Diagnostic Care Center
Nuclear Medicine, Pulmonary, Sleep Study, blood draw, Heart
Station, Neurophysiology (EEG), and Pre-Admission Testing.
SECOND FLOOR
ExpressER
Treatment for minor bumps and bruises, simple cuts and
broken bones ... with LVHHN's full service Emergency
Department right around the comer if needed.

Bum Center
A large family room and overnight accommodations designed
for families who travel from outside the Lehigh Valley.
Intensive Care Unit
This 28-bed unit combines medical, surgical and trauma-neuro
intensive care focusing on care of the patient as well as
convenience of the family.

Thomas C. Dotson, MD, Division of General Internal
Medicine, was recently notified by the American Board of
Internal Medicine that he passed the August 1999 Certification
Examination and is now certified as a Diplomate in Internal
Medicine.
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Papers, Publications and Presentations
Herbert L. Hyman, MD, Division of Gastroenterology, spoke
on Chronic Fatigue Syndrome at Fellsmere Medical Center in
Fellsmere, Fla., in early November.

lndru T. Khubchandani, MD, Division of Colon and Rectal
Surgery, was the invited speaker at the XVI Latin American
Congress of Coloproctology held in Santiago, Chile, from
October 28 to 31. At the meeting, Dr. Khubchandani gave the
Bacon Oration titled "Colectomy and lleorectal Anastomosis in
Ulcerative Colitis." He was also a member of the panel
discussion on "Controversies in the Surgical Treatment of
Hemorrhoids" and showed two videos of surgical techniques of
"Transanal Repair of Rectocele" and "Resection for
Colovesical Fistula with Hand Sewn Anastomosis."
In addition, Dr. Khubchandani attended the meeting of the
Northeastern Society of Colon and Rectal Surgeons held in
Palm Beach, Fla., from November 7 to 10. Dr. Khubchandani
spoke on "Refinements in the Technique of Closed
Hemorrhoidectomy" and moderated a panel titled "How do you
do it?"
The Northeastern Society of Colon and Rectal Surgeons
meets annually and is a composite conference of the
Pennsylvania Society of Colon and Rectal Surgeons, the New
York Society of Colon and Rectal Surgeons, the New Jersey
Society of Colon and Rectal Surgeons, and the New England
Society of Colon and Rectal Surgeons.
Alan B. Leahey, MD, Associate Chief, Division of
Ophthalmology, recently authored a book chapter-"Molluscum Contagiosum" which appears in Current Ocular
Therapy, edited by Fraunfelder and Roy.
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January 4 - "What Difference Does Difference Make:
Culture, Religion and Ethnicity in the Medical Setting"
January 11 - To Be Announced
January 18 - Occupational Lung Diseases
January 25- Trauma and the Geriatric Patient

For more information, please contact Diane Biernacki in the
Department of Medicine at (610) 402-5200.

Department of Pediatrics
The Department of Pediatrics conferences are held on Fridays
beginning at noon in the auditorium of Lehigh Valley Hospital,
171h & Chew.
The topics for January will be:
~
~

January 14 - Adolescent Medicine
January 28 - Dermatologic Problems in Infants

For more information, please contact Kelli Ripperger in the
Department of Pediatrics at (610) 402-2540.

Trends in the Treatment of Peripheral
Vascular Disease
"Trends in the Treatment of Peripheral Vascular Disease," a
symposium sponsored by the Circulatory Center, will be held on
Saturday, February 5, 2000, from 7:30a.m. to 12:15 p.m., in the
Auditorium of Lehigh Valley Hospital at Cedar Crest & 1-78.
Cardiologists, cardiothoracic surgeons, radiologists, and
vascular surgeons will benefit from this program.

Upcoming Seminars, Conferences and
Meetings

Controversies in peripheral angioplasty from the perspectives
of a cardiologist, vascular surgeon, and interventional
radiologist will be discussed. State-of-the-art and national
trends will be presented by David Katz, MD, JD, Senior
Director of Medical Affairs with the Advisory Board Company.

Medical Grand Rounds

For additional information, please contact Sherry Haas in Care
Management Systems at (610) 402-1770.

Medical Grand Rounds are held every Tuesday beginning at
noon in the auditorium of Lehigh Valley Hospital, Cedar Crest
& 1-78, and via videoconference in the First Floor Conference
Room of Muhlenberg Hospital Center. Beginning in January,
Medical Grand Rounds will also be videoconferenced to 17tn &
Chew every Tuesday at noon. This interactive Medical Grand
Rounds will be televised in the VTC Room, formerly the
Medical Staff Lounge, adjacent to the cafeteria on the first
floor.
Topics to be discussed in January will include:
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Who's New
Medical Staff
Appointments
Suzette V. Barreto, MD
Eric Schoeppner, MD, PC
1725 Northampton Street
Easton, PA 18042-3133
(610) 253-7211
Fax: (610) 252-8685
Department of Medicine
Division of General Internal Medicine
Site of Privileges - LVH & MHC
Provisional Active

*

Joseph C. Bognet, DO
Bognet Medical Associates, PC
451 Chew Street, Suite 304
Allentown, PA 18102-3423
(610) 821-2820
Fax: (610) 821-9577
Department of Family Practice
Site of Privileges - LVH & MHC
Provisional Active

*

Dennis B. Cornfield, MD
Health Network Laboratories
Lehigh Valley Hospital
17th & Chew, P.O. Box 7017
Department of Pathology
Allentown, PA 18105-7017
(610) 402-2237
Fax: (610) 402-9692
Department of Pathology
Division of Hematopathology
Site of Privileges - LVH & MHC
Provisional Active

*

Albert N. Dandegian, MD
Medical Imaging of LV, PC
Muhlenberg Hospital Center
2545 Schoenersville Road
Bethlehem, PA 18017-7384
(610) 861-2271
Fax: (610) 867-7376
Department of Radiology/Diagnostic Medical Imaging
Division of Diagnostic Radiology
Site of Privileges - LVH & MHC
Provisional Active

*

Becky M. Fox, DMD
Elizabethtown Dental Associates
100 Continental Drive
Elizabethtown, PA 17022
(717) 367-1336
Fax: (717) 367-7904
Department of Dentistry
Division of General Dentistry
Site of Privileges - LVH & MHC
Provisional Active

*
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Barry E. Herman, MD
Twin Rivers Gastroenterology Center
20 Community Drive
Easton, PA 18042-2658
(610) 258-6635
Fax: (610) 258-2879
Department of Medicine
Division of Gastroenterology
Site of Privileges - MHC
Provisional Active

*

Shashi L. Kumar, MD
LVPG-Pediatric Surgery
Allentown Medical Center
401 N. 17th Street, Suite 302
Allentown, PA 18104-5050
(610) 402-7999
Fax: (610) 402-7901
Department of Surgery
Division of Pediatric Surgery
Site of Privileges - LVH & MHC
Provisional Active

*

Pamela F. LeDeaux, MD
Lehigh Valley Family Health Center
1730 Chew Street
Allentown, PA 18104-5595
(610) 402-3500
Fax: (610) 402-3509
Department of Family Practice
Site of Privileges - LVH & MHC
Provisional Active

*

Timothy C. Lin, DMD
Joseph A. Silvaggio, DMD, PC
1991-B Catasauqua Road
Allentown, PA 18103-1104
(61 0) 866-8989
Department of Dentistry
Division of Endodontics
Site of Privileges - LVH & MHC
Provisional Active
Daniel J. Miller, MD
Neurosurgical Associates of LVPG
1240 S. Cedar Crest Blvd., Suite 308
Allentown, PA 18103-6264
(610) 433-6166
Fax: (610) 820-5357
Department of Surgery
Division of Neurological Surgery
Site of Privileges- LVH & MHC
Provisional Active

*

Shanker Mukherjee, MD
Twin Rivers Gastroenterology Center
20 Community Drive
Easton, PA 18042-2658
(610) 258-6635
Fax: (610) 258-2879
Department of Medicine
Division of Gastroenterology
Site of Privileges - MHC
Provisional Active

*
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Charles J. Perruzzi, Jr., DMD
88 W. Ridgewood Avenue
Ridgewood, NJ 07450
(201) 652-8875
Fax: (201) 848-0087
Department of Dentistry
Division of General Dentistry
Site of Privileges - LVH & MHC
Provisional Active

*

Carla M. Rossi, MD
3735 Nazareth Road, Suite 201
Easton, PA 18042-8751
(610) 923-9663
Fax: (610) 923-9661
Department of Medicine
Division of Infectious Diseases
Site of Privileges - MHC
Provisional Active

*

Christian F. Sorensen, MD
Trexlertown Medical Center
6900 Hamilton Blvd., P.O. Box 127
Trexlertown, PA 18087-0127
(610) 402-0101
Fax: (610) 402-0102
Department of Family Practice
Site of Privileges - LVH & MHC
Provisional Active

*

G. Edward Streubert, MD
Medical Imaging of LV, PC
Muhlenberg Hospital Center
2545 Schoenersville Road
Bethlehem, PA 18017-7384
(610) 861-2271
Fax: (610) 867-7376
Department of Radiology/Diagnostic Medical Imaging
Division of Diagnostic Radiology
Site of Privileges - LVH & MHC
Provisional Active

*

Deborah W. Sundlof, DO
Lehigh Valley Cardiology Associates
2597 Schoenersville Road, Suite 202
Bethlehem, PA 18017-7396
(610) 866-2233
Fax: (610) 866-7738
Department of Medicine
Division of Cardiology
Site of Privileges - LVH & MHC
Provisional Active

*

Joseph G. Trapasso, MD
Urologic Associates of Allentown Inc.
1240 S. Cedar Crest Blvd., Suite 310
Allentown, PA 18103-6218
(610) 437-9988
Fax: (610) 437-4320
Department of Surgery
Division of Urology
Site of Privileges - LVH & MHC
Provisional Active

*
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Laura R. West, MD
In practice with Paul K. Gross, MD
Allentown Medical Center
401 N. 17111 Street, Suite 304
Allentown, PA 18104-5104
(610) 820-3900
Fax: (610) 820-3835
Department of Psychiatry
Site of Privileges - LVH & MHC
Provisional Associate

*

Address Changes
Fernando M. Garzia, MD
(No longer associated with Bethlehem Cardiothoracic Surgical
Associates, PC)
Opcor P.C.
1941 Saucon Lane
Bethlehem, PA 18015-5242
(610) 866-6880
Fax: (610) 866-6886
The Heart Care Group, PC
~ lan Chan, MD
~
David B. Goldner, MD
~ William M. Markson, MD
~ Ronald A. Stein, MD
451 Chew Street
Suite 104
Allentown, PA 18102-3423
(610) 821-2841
Fax: (610) 821-9700
John D. Heid, DO
Family Doctor, Inc.
1040 Chestnut Street
Emmaus, PA 18049-1998
(610) 966-5549
Fax: (610) 967-0204
Michele D. Jones, DO
(No longer associated with Riverside Medical Associates)
The Pottsville Hospital and Warne Clinic
420 S. Jackson Street
Pottsville, PA 17901-3692
(570) 621-5069
Fax: (570) 621-5591
Ravindra R. Kandula, MD, PC
~
Ravindra R. Kandula, MD
~ T. Kumar Pendurthi, MD, PhD
2657 Schoenersville Road
Bethlehem, PA 18017-7316
Syed A. Subzposh, MD
(No longer associated with The Heart Care Group)
451 Chew Street
Suite 302
Allentown, PA 18102-3423
(610) 821-2810
Fax: (610) 821-6952
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Appointment to Medical Staff Leadership Positions

Leaves of Absence

Oscar A. Morffi, MD
Department of Pediatrics
Position: Vice Chairperson, Department of Pediatrics

William W. Frailey, Jr., MD
Department of Surgery
Division of Surgery
Two-Year Leave of Absence

Joseph G. Trapasso, MD
Department of Surgery
Position: Director of Urologic Oncology
John & Dorothy Morgan Cancer Center

Status Changes
ln-Ho Chang, MD
Department of Anesthesiology
From: Active
To: Honorary
Lawrence P. Levitt, MD
Department of Medicine
Division of Neurology
From: Active
To: Affiliate
Walter K. Peters, MD
Department of Medicine
Division of General Internal Medicine
From: Limited Duty
To: Honorary
Eric J. Schenkel, MD
Department of Medicine
Division of Allergy
From: Associate
To: Affiliate
Prakash N. Shah, MD
Department of Medicine
Division of General Internal Medicine
From: Provisional Active
To: Associate
Amar J. Sharma, MD
Department of Medicine
Division of Allergy
From: Active
To: Associate
Julie A. Stern, MD
Department of Pediatrics
Division of Hematology/Medical Oncology
From: Provisional Associate
To: Provisional Active
Douglas C. Wiseman, DO
Department of Medicine
Division of Allergy
From: Active
To: Associate

Daniel J. Kelley, MD
Department of Surgery
Division of Otolaryngology-Head & Neck Surgery
Additional One-Year Leave of Absence
David B. Sussman, MD
Department of Surgery
Division of Orthopedic Surgery
Section of Ortho Trauma
Six-Month Leave of Absence
Anne E. VonNeida, MD
Department of Medicine
Division of General Internal Medicine
One-Year Leave of Absence

Resignations
Hassan Bozorgnia, MD
Department of Pediatrics
Division of General Pediatrics
Ahna S. Chu, MD
Department of Radiology/Diagnostic Medical Imaging
Division of Diagnostic Radiology
Jay S. Cowen, MD
Department of Medicine
Division of Pulmonary
Gregory Egan, MD
Department of Radiology/Diagnostic Medical Imaging
Division of Diagnostic Radiology
Jacqueline A. Evans, DO
Department of Obstetrics and Gynecology
Division of Gynecology
Mark B. Farin, MD
Department of Pediatrics
Division of Cardiology
Lisa A. Fedullo, MD
Department of Radiology/Diagnostic Medical Imaging
Division of Diagnostic Radiology
Hal L. Folander, MD
Department of Radiology/Diagnostic Medical Imaging
Division of Diagnostic Radiology
Diane Garrigan, DO
Department of Radiology/Diagnostic Medical Imaging
Division of Diagnostic Radiology
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Gregory D. Harvey, MD
Department of Radiology/Diagnostic Medical Imaging
Division of Diagnostic Radiology
Ellen A. Redstone, MD
Department of Radiology/Diagnostic Medical Imaging
Division of Diagnostic Radiology
Michael I. Rothman, MD
Department of Radiology/Diagnostic Medical Imaging
Division of Diagnostic Radiology
Vitaly Sawyna, MD
Department of Surgery
Division of General Surgery
Gregg D. Schubach, MD
Department of Radiology/Diagnostic Medical Imaging
Division of Diagnostic Radiology

Allied Health Professionals
Appointments
Stacy A. Benner, PA
Physician Extender
Physician Assistant - PA
(Lehigh Neurology- Alexander D. Rae-Grant, MD)
Site of Privileges - LVH & MHC
Alyssa A. Dwyer, CRNP
Physician Extender
Professional - CRNP
(CHOP-Pediatric Hematology/Oncology- Julie W. Stern, MD)
Site of Privileges - LVH & MHC
Kirandeep K. Gill, CRNP
Physician Extender
Professional - CRNP
(CHOP-Pediatric Hematology/Oncology- Julie W. Stem, MD)

Site of Privileges - LVH & MHC

Patricia A. Landis, CST
Physician Extender
Technical- Surgical Technician
(Orthopaedic Associates of Bethlehem, Inc. -Stephen P. Falatyn, MD)
Site of Privileges - MHC
Nancy M. Montgomery, RN
Physician Extender
Professional- RN
(The Heart Care Group, PC -Joseph L. Neri, DO)
Site of Privileges - LVH & MHC
Daniele A. Shollenberger, CRNP
Physician Extender
Professional- CRNP
(Neurosurgical Associates of LVPG - Mark C. Lester, MD)
Site of Privileges- LVH & MHC
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William J. Waldron, CRNA
Physician Extender
Professional - CRNA
(Allentown Anesthesia Associates Inc - Alphonse A. Maffeo, MD)
Site of Privileges- LVH & MHC

Resignations
Amber J. Herring
Physician Extender
Technical- Dental Assistant
(Marsha A. Gordon, DDS)
Steven L. Muthler, CRNA
Physician Extender
Professional - CRNA
(Allentown Anesthesia Associates Inc)
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THERAPEUTICS AT A GLANCE
The following actions were taken at the November 1999 Therapeutics Committee Meeting- Clinical Pharmacy Services Joseph
Ottinger, R.Ph., MS, MBA, Christopher Moore, R.Ph., James Sianis, Pharm.D., Eric Barber, Pharm.D. Candidate

ADR Reporting
AD R reporting for the second quarter
continued to mirror previous periods as
regards manifestations and the reporting
parameters summarized in the tables below.
Reporting incidence ratios defined as
reports per 10,000 doses and reports per
1,000 adjusted admissions continue to
plateau after a period of decline, this
despite increased reporting amongst nursing
staff personnel. The availability of the
unit-based pharmacists may have
contributed in some manner to the overall
decline in ADR rates over the past 2 years.
In addition to the quarterly report, at least
two case reports of bleeding following the
administration of 'treatment doses' of
lovenox = enoxaparin (lmg/kg q12h) were
detailed (3rd quarter data). Both patients
had estimated creatinine clearance values of
< 30 ml/min. To date, this patient
population has been excluded from all the
published enoxaparin studies. It is assumed
that this group of patients will accumulate
drug to some degree, but a formalized
recommendation as to what extent dosing
should be altered has not been published.
Monitoring aPTTs in LMWH therapy does
not provide any insight as to the level of
coagulation. The ideal method of
assessment would be use of anti-factor Xa
heparin levels (0. 3-0.7 units/ml =
therapeutic), but they are currently not
routinely available. The Therapeutics
Committee recommended that a note be
placed in the 'progress notes' section (will
not be a permanent part of the chart) to

alert physicians when this situation is
identified to renal dose. A copy of this
notification is included in this newsletter.
Following are the particulars for this
quarter:
Second Quarter Data
Table 1: Adverse Reactions By Reporter
Reporter
# Reports % Reports
Pharmacist
39
54.9
Nurse
24
33.8
X-Ray Technician
8
11.2
0
0
Physician
TOTAL
71
100

Table 2: Adverse Reactions By Drug Category
% Reports
Drug Category
# Reports
27
38
Antibiotics
10
14.1
Contrast Dyes
Psych/Neurologic Agents
0
0
Narc otic Analgesics
13
18.3
Abciximab/heparin/TPA
8
11.3
Dopamine
1
1. 4
3
4.2
Cardiac
Other
9
12.7
TOTAL
62
100

Table 3: Probability of Drug-Related Reactions
% Reports
Probability
# Reports
Doubtful
0
0
Possible
23
32.4
Probable
44
62
Highly Probable
4
5.6
TOTAL
71
100
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Table 4: Adverse Reaction Severity
Classification
# Reports
% Reports
Mild

Moderate
Severe
TOTAL

34
32
5

47.9
45
7.1

71

100

Enoxaparin Notification
Dear Doctor: Use of enoxaparin(Lovenox)
in patients with compromised renal function
in treatment regimens utilizing the lmg/ kg
q12h dosing has not been studied. All
published data to date have EXCLUDED
this patient population, therefore no dosing
guidelines are available to direct therapy in
these individuals. There is data to suggest
that the excretion of LMWHs will be
reduced in moderate renal failure, leading
to drug accumulation and a higher risk of
bleeding. As LMWH's effects on
anticoagulation cannot be monitored via
"standard" laboratory measures, it would
seem prudent to consider using another
agent for anticoagulation. Therapeutic
unfractionated heparin is generally
considered equally effective and safe in all
indications where treatment regimens of
enoxaparin are currently approved. Thank
you for your cooperation.

Nasal Steroid Preparations
To minimize therapy delays, unnecessary
physician time spent handling formulary
issues, and "inventory clutter", the
Therapeutics Committee has approved an
automatic substitution procedure for the
currently available nasal steroid products.
The guidelines and their rationale are
outlined below:

Automatic Substitution Guidelines for
Corticosteroid Nasal Inhalation
Formulations:
All doses indicated for the products

listed below will be automatically
substituted with budesonide (Rhinocort or
Rhinocort AQ) products at a dose of onetwo sprays into each nostril twice daily
unless the patient is allergic to budesonide.
The substitution will proceed based on the
initial formulation ordered and the initial
quantity of 'sprays'. Aqueous formulations
will be changed to Rhinocort AQ and nonaqueous products will be modified to
Rhinocort. The number of 'sprays' per
nostril will be continued into the new
"substitution" order. No more than eight
activations per day will be ordered. The
pharmacist will write a clarifying order that
will address this change in a timely fashion
consistent with the relevant automatic
substitution policies previously identified.
Drug Name (Brand)/ Generic
Dose per inh
Vancenase, Beconase
Beclomethasone
42mcg

Beclomethasone AQ

42mcg

Beclomethasone AQ-DS 84mcg

Recommended
Doses#
1-2 spray(s) each
nostril 4 times/day
1-2 spray(s) each
nostril 2x/day
1-2 spray(s) each
nostril/day

Nasalide, Nasarel
Flunisolide

25 meg

1-2 sprays each
nostril2x/day

Flonase
Fluticasone

50 meg

1-2 sprays each
nostril/d or 1
spray each nostril
2x/day

Nasonex
Mometasone

50 meg

1-2 sprays each
nostril/day

Nasacort, Nasacort AQ
Triamcinolone
55 meg

1-2 sprays each
nostril /day
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Rationale:
No current product has been shown
to be any more effective or safer in
the patient population outlined
(patients > 6 yo).
Budesonide may have a lower risk
of suppressing the HPA axis at
higher doses.
Cost issues appear to be translated
for budesonide products across the
inpatient to outpatient continuum.
The ability to provide once daily
dosing (thereby, improving the
chances of compliance as an
outpatient) is available with this
product, but will not be
incorporated into the automatic
substitution guideline at this time.

Herbal Remedies And
Important Aspects of Herbal
Therapy
This educational effort was designed not to
provide an all-encompassing review of
herbal products, vitamins or alternative
health products. There are numerous texts
and other references that are now available
to provide such information. This review
will however provide a background about
the recent explosion of alternative
medications in today' s society. The goal of
this article is to provide the reader with
some examples of these products, potential
interactions, and contraindications that
should be observed.
Even in today' s complex health care system
25 % of prescription medications are still
derived from plants.' Common examples
of these drugs that are supported by
controlled clinical trials and have gained
widespread acceptance in the medical
community are colchicine, morphine,

pilocarpine, paclitaxel and many others. 2
After the ratification of the DSHEA in
1994, the use of herbal remedies in the
United States has skyrocketed. Today
there are approximately 500 different herbs
marketed in the U.S. today. In 1996, a
survey done by International
Communications Research demonstrated
that the top ten herbs accounted for almost
50% of herbal product sales. 3
With the passage of the DSHEA the
distinction between a medication and food
is not always easy to make. A food is
defined as articles or components used for
food or drink. An example of this type of
product is Benecol, which is a food, but
has been "clinically proven to reduce
LDL.... up to 14%". Since the definition of
a drug is a therapeutic agent other than
food used in the prevention, diagnosis,
alleviation, treatment, or cure of disease, 4 it
is easy to become confused.
Since the introduction of these products
into the marketplace, information has been
coming to light about possible drug/drug
interactions with these products and
prescription drugs. Several supplements
have also been deemed to be unsafe by the
FDA. Since there can be drug interactions
with prescription medications that these
patients are taking, both patients and their
health care providers need to be aware of
the potential for these interactions. The
potential magnitude of this situation was
realized after a recent study done here at
Lehigh Valley Hospital. The following is a
summary of the study findings.
Hospitalized adult patients were eligible for
enrollment in this study if they were
admitted to LVH (Cedar Crest site) for any
reason. Patients were chosen at random.
Patients were excluded from this study if
they were admitted from a nursing home,
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unable to answer questions, have a history
of dementia or under the age of 18. A
pharmacist interviewed the majority of
patients and a pharmacy student
interviewed eight of the patients. The
subjects were asked the following questions
in the following order: 1. Do you take any
vitamins or herbal supplements? 2. Do you
know what I mean when I say herbal
supplement? 3. Do you take any over the
counter or any medications that you do not
need a prescription for?
Once this was accomplished, these results
were compared against the results obtained
by a registered nurse during the initial
patient interview. The format is outlined in
the Lehigh Valley Hospital Admission
Record Part 1- Patient Questionnaire. This
form asks the specific question: Are you
taking any medications - List all prescribed
and non-prescribed. (Form NSG-202-1)
A total of 104 patients were evaluated. Of
the 104 patients interviewed, 18 patients
were taking herbal remedies. (17.3%). For
the last fiscal year 1998-99, there were
30,727 admissions to Lehigh Valley
Hospital. If we apply the same percentage
of patients in our small survey to the total
number of admissions, an estimated 5,000
patients yearly will be admitted to LVH
that consume herbal remedies. As you can
see, these products have significantly
affected our community. To provide you
with an idea of the potential interactions
that can arise, a list of the top selling herbs
in 1998 and their potential interactions has
been provided. These are the agents that
you are likely to see in clinical practice.
Top Selling Herbs
1.
2.
3.

9

Echinacea
Garlic
Gingko

4.
5.
6.
7.

8.
9.
10.
11.
12.

13.
14.
15.
16.

17.
18.
19.
20.

Golden Seal
Saw Palmetto
Aloe
Panax Ginseng
Astralgus
Cayenne
Cat's Claw
Siberian Ginseng
Bilberry
Cranberry
Dong Quai
Grape Seed
Cascara
St. John's Wart
Valerian
Ginger
Feverfew

Specific Product Interactions/ Contraindications with the top 20 herbal products
Echinacea- avoid in progressive systemic
diseases such as tuberculosis, collagenosis,
multiple sclerosis. Avoid in patients with
diabetes.
Garlic- Can interact with aspirin,
dipyridamole, and warfarin
Gingko Biloba- Can interact with
anticoagulants such as aspirin, warfarin,
dipyridamole. 7
Goldenseal- contraindicated in patients with
high blood pressure
Saw Palmetto- May affect existing
hormonal therapy. 10
Ginseng- Can lower blood sugar, can
interact with diabetes medications.
Dong Quai- Can have antiplatelet/
anticoagulant activity. Contraindicated in
pregnancy.
Grapeseed Extract- Used as an antioxidant
'
for diabetic retinopathy. Can interact with
antiplatelet drugs and warfarin.
Cat's Claw- Contraindicated in patients
who are planning or have recently had skin
grafts or organ transplants. Not
recommended for hemophiliacs who are
receiving
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cryoprecipitate or FFP. Not recommended
to be combined with passive vaccines
composed of animal sera, intravenous
thymic extracts, insulin (bovine or porcine)
or other hormone therapies with animal
proteo or peptide hormones. 11 Has been
used as an abortifacient in traditional
Peruvian medicine.
Eleuthero (Siberian Ginseng)- Can
exacerbate hypertension, avoid in patients
with anxiety, mania, schizophrenia.
St. John's Wort- Should not be used at the
same time as prescription antidepressants.
Ginger Rhizome- Due to in vitro antiplatelet activity and in vivo hypoglycemic
activity, it is believed by some that
excessive doses of ginger can interfere with
these therapies. 7 Caution is advised in
patients with gallstones.
As you can see, even with the limited
information presented here, there are
numerous potentials for interactions with
prescription medications. Therefore at
Lehigh Valley Hospital, we have
recommended the following changes to the
current procedures. When a patient is
admitted, physicians may want to ask the
specific question during the H +P, which
states "do you take any vitamins or herbal
medicines" .
From a nursing standpoint, Nursing
Practice Council has accepted
recommendations that the Admission
Record Part 1- Patient Questionnaire (form
NSG-202-1) be altered. Final alterations
have yet to be determined. Until that time
it is recomrriended that the nursing staff
continue to ask the question 11 are you taking
any medications?". In addition, the
question 11 do you take any vitamins or
herbal medicines" should be asked as well.
If the answer to the second question is yes,
pharmacy should be notified. In that way,

the herbal remedy can be identified and
added to the patients medication profile.
The pharmacist shall screen for drug/ drug
interactions. If any problems are found the
pharmacist shall contact the physician via
phone or by a note left in the chart. From
this point, the medication may be used in
the hospital according to patients own
medication policy. (The patient's family
should bring in their own supply). Please
keep in mind that physicians are required to
write an order for any product to be used
by the patient's own medication policy.
Please keep in mind however that this is for
continuation of ongoing therapy only.
Patients should not be STARTED on an
herbal remedy at L VH. We are currently
evaluating references to be made available
to all members of the L VH network. It is
our hope that once the decision is made, it
will be available by the intranet or similar
access. Until then, feel free to contact the
clinical pharmacy office with questions
about these products. There is also
information available on the internet.
Some of the more commonly used sites
have been provided.
Reliable resources for herbal information
American Botanical Association
www .herbalgram.org
American Pharmaceutical Association
www.aphanet.org
American Society of Pharmacognosy
www .temple.edu.ASP
Food and Drug Administration
www.fda.gov
FDA Guide to Dietary Supplements
www.fda.gov/fdac/features/1998/598 guid.html
Herb Research Foundation
www .herbs.org
National Institutes of Health
www .nal. usda.gov/fnic/IBIDS/
Office of Alternative Medicine
www .altmed.od.nih.gov
Pharm Infonet
www. pbarminfo.com
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Pharmacist's Web Guide
www .geocities.com/Heartland/Oaks/1591
Urban Legends and Folklore
urbanlegends. mining co. com/library /htm
US Pharmacopeia
www.usp.org
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Resistance Rumors
It is being reported, by unknown
individuals, that Streptococcus pneumoniae
is 30% resistant to levofloxacin at Lehigh
Valley Hospital. The fact of the matter is
that there are no resistance problems with
levofloxacin and Streptococcus
pneumoniae. The microbiology department
has been doing susceptibility testing since
this agent was added to formulary. There
were 88 isolates tested from October 1998
to November 1999 and 92% were
susceptible. Macrolides on the other hand
have not fared as well. Presently, there is
25% resistance with Streptococcus
pneumoniae. Currently, the hospital is
only testing erythromycin, but the results

can be used to interpret susceptibilities for
other macrolides (Zithromax, Biaxin).
Based on current LVH resistant patterns,
macrolides would not be good empiric
monotherapy choices if Streptococcus
pneumoniae is the presumed organism.
Ceftriaxone and levofloxacin are still
excellent options for the treatment of
community acquired pneumonia. If
ceftriaxone is chosen, and atypical
coverage is needed, then a macrolide is
appropriate. Levofloxacin can be used
monotherapy to cover the usual suspects in
community -acquired pneumonia as well as
the atypicals. When questions about
resistance patterns in the hospital arise,
please refer to the LVH Antibiogram or
contact the Clinical Pharmacy Office, the
Infectious Disease Division or the
Microbiology Department. Antibiograms
are located in the back of each patient
chart. If you would like your own copy,
please contact the Clinical Pharmacy Office
(Ext. 8884) and we will provide you with
one. Please use information concerning
resistance patterns from pharmaceutical
representatives with caution. They can
often times be misinformed. If you have
any questions, please contact me in the
clinical pharmacy office.

Two New 'Glitazones" Added
The two recently approved "Rezulin" type
agents were approved to the drug
formulary. The status of troglitazone
(Rezulin) has not changed. It will continue
to be available until further data is obtained
related to the safety of pioglitazone (Actos)
and rosiglitazone (Avandia). A comparison
chart for all the agents in this class is
included in this newsletter.

Thiazolidinediones

,-Generic Name
(Trade Name)

Usual Dose

Max Dose

Mean FBG (mg/dl) &
HbA1C (%)decrease

Contraindications

Monitor

Cost (AWP)
per 30 tablets

Notes

Troglitazone
(Rezulin)
*Eli Lilly

200 mg qd with food
in combination
therapy.

( p 2-4 weeks )
t to 400 mg qd,
(p 2-4 weeks )
t to 600 mg qd
in combination therapy
with sulfonylureas,
metformin, or insulin.

(with glyburide)
200 mg qd ( -31 /-0.7)
400 mg qd ( -38/-0.9)
600 mg qd ( -56/-1.8)

ALT 1.5 x upper limit,
NYHA Class 3 and 4,
Preg Category 8,
Nursing Mothers,
Type 1 OM or DKA

FBG and HbA1c,

200 mg $ 74.59
300 mg $74.59
400 mg $ 118.80

..J,•s BCP's by 30%,
Add or t
contraception.

( p 12 weeks)
tto 8 mg qd
in 1-2 doses,
in monotherapy or
combination therapy
with metformin or
insulin.

2 mg bid ( -38/-0.3)
4 mg qd ( -25/ 0.0 )

ALT 2.5 x upper limit,
NYHA Class 3 and 4,
Preg Category C,
Nursing Mothers,
Type 1 OM or DKA

2 mg $43.61
4mg $60.15
8 mg $ 109.78

Anovulatory may
resume ovulation,
Use adequate
contraception.

200 mg tablets
300 mg tablets
400 mg tablets

Rosiglitazone
(Avandia)
*SKB

Initial monotherapy
not recommended.

4mgqd
in 1-2 doses,
monotherapy or
combination therapy.

2 mg tablets
4 mg tablets
8 mg tablets

*with or without food

Pioglitazone
(Actos)
*Parke-Davis

15-30 mg qd
monotherapy or
combination therapy.

15 mg tablets
30 mg tablets
45 mg tablets

*with or without food

45 mg qd,
in monotherapy.
30 mg qd in
combination therapy
with sulfonylureas,
metformin, or insulin.

4 mg bid ( -54/-0.6 )
8 mg qd ( -42/-0.3 )

15 mg qd ( -30 I -0.3 )
30 mg qd ( -32/ -0.3 )
45 mg qd ( -56/-0.9)

ALT 2.5 x upper limit,
NYHA Class 3 and 4,
Preg Category C,
Nursing Mothers,
Type 1 OM or DKA

Initial liver enzymes,
monthly x 1 year,
then every 3
months.

FBG and HbA 1c,
Initial liver enzymes,
then every 2 months
x 12 months.

FBG and HbA1c,
Initial liver enzymes,
then every 2 months
x 12 months.

15 mg $71.43
30 mg $ 114.37
45 mg $ 124.06

h

BCP's by 30%,
Add or t
contraception.

Mechanism of Action:
Thiazolidinediones act primarily by decreasing insulin resistance. They improve sensitivity to insulin in muscle and adipose tissue and inhibit hepatic gluconeogenesis. When used in
combination therapy and hypoglycemia is reported, it is recommended that the dose of the second agent be reduced.
Renal Dosage Adjustments:
No dosage adjustments are required.
Hepatic Dosage Adjustments:
Thiazolidinediones should not be initiated in patients with clinical evidence of active liver disease or elevated serum transaminase (ALT).
Lab Abnormalities:
There may be an increase in total cholesterol, LDL, HDL, and FFA's , and a decrease in triglycerides, hematocrit (up to 4% difference) and hemoglobin {up to 1 gm/dl difference) with
the use of thiazolidinediones.
In treatment of premenopausal, anovulatory woman with insulin resistance, the addition of thiazolidinediones may result in resumption of ovulation. These patients may be at risk for
pregnancy if adequate contraception is not used.
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HOSPITAL

THERAPEUTICS AT A GLANCE
Th~

following actions were take~ at the December 1999 Therapeutics Committee Meeting- Clinical Pharmacy Services Joseph
Ottmger, R.Ph., MS, MBA, Chnstopher Moore, R.Ph., James Sianis, Pharm.D.

Loop Diuretic Autosubstitution
The Therapeutics Committee approved the
autosubstitution of furosemide for
torsemide during the last committee
meeting. This substitution includes both
the intravenous and oral formulations. Both
agents have an identical mechanism of
action and there is no therapeutic advantage
to using torsemide instead of furosemide.
Orders written for torsemide will be
substituted with furosemide on a two for
one basis. If a patient is to be switched
back to torsemide after discharge,
remember to make the appropriate dosage
adjustment. Please direct any questions or
comments to the Clinical Pharmacy Office.

IV to PO Step Down Additions
Four medications were added to the IV to
PO Step Down Program during the last
meeting of the Therapeutics Committee.
These agents are azithromycin IV, enalapril
IV, metoprolol IV and metronidazole IV.
Azithromycin (Zithromax®) will be
converted to the oral formulation per the
package insert. Azithromycin 500 mg IV
will be converted to 250 mg PO q24h. If
the patient is on 250 mg IV then that will
be converted to 250 mg PO q24h.
Metronidazole will be converted to the oral
formulation on a mg per mg basis. The
dosing interval will remain the same.
Enalapril IV will be substituted with
enalapril 5mg PO qd if the patient is not
receiving a loop diuretic and titrated
upward as necessary by the physician. If
the patient is receiving a loop diuretic the
IV will be converted to 2. 5 mg qd and

titrated upward as necessary. Orders for
enalapril written on an as needed basis will
not be converted to PO. Metoprolol 2.5
mg IV q6h will be converted to metoprolol
12.5 mg PO q12h. Metoprolol 5 mg IV
q6h will be converted to 25 mg PO q 12h.
Orders written on an as needed basis will
not be converted to PO. Please keep in
mind that dosage titration may be required
for the antihypertensive agents. Please
direct any questions or comments to the
Clinical Pharmacy Office.

ADR Reporting 3rd Quarter
ADR reporting for the third quarter
continued to mirror previous periods as
regards manifestations and the reporting
parameters summarized below. Incidence
ratios have increased by modest increments
in each quarter's data, but remain
significantly below 1998 levels. Reporting
incidence ratios are defined as reports per
10,000 doses and reports per 1, 000
adjusted admissions. They were 0.8 and
7.15, respectively. Last quarters rates
were 0.74 and 6.73, respectively.
Following are the particulars for this
quarter:
Third Quarter Data
Table 1: Adverse Reactions By Reporter
Reporter
#Reports
Pharmacist
53
Nurse
12
X-Ray Technician
6
Physician
~
TOTAL
73

% Reports
72.6
16.4

8.2
2.8
100
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Table 2: Adverse Reactions By Drug Category

# Regorts

Drug Category
Antibiotics
Contrast Dyes
Psych/Neurologic Agents
Narcotic Analgesics
Abciximab/heparin!TP A
Dopamine
Cardiac
Oncology
Other
TOTAL

33
7
4
4
15
0
2
3

% Regorts

45.2
9.6
5.5
5.5
20.5
0
2.7
4.1
6.8
100

~

73

Table 3: Probability of Drug-Related Reactions/
# Regorts
Probability
0
Doubtful
30
Possible
42
Probable
Highly Probable
1..
73
TOTAL

% Regorts
0
41.1

57.5
1.4
100

Table 4: Adverse Reaction Severity
Classification
Mild
Moderate
Severe
TOTAL

# ReQorts

24
41
8
73

% Regorts
32.9
56.2
11.0
100

Enoxaparin Treatment doses
Due to the product concentration of
enoxaparin and the practical matter of
preparing doses, the pharmacy will "round"
all 1mg/kg q 12h dosing regimens to the next
lowest 5mg dose increment. For example,
an 83 kg patient would receive an 80mg
dose every 12 hours.

Revised 'Stalin' Autosubstitution
All cerivastatin (Baycol) dosing schemes
will be automatically substituted with
simvastatin at comparable doses. All agents
in this class of drugs are now addressed by
this revision. See table above delineating
this conversion.

Drug/dose
Ordered

Autosubstitution

Cerivastatin
(Baycol)
0.2mgPOQD
0.3mgPOQD
0.4mg PO QD

simvastatin (Zocor)
5mg PO QD 1800
10mg PO QD 1800
20mg PO QD 1800

·fluvastatin
(Lescol)
20mg PO QD
40mg PO QD
80mg PO QD

simvastatin (Zocor))
5mg PO QD 1800
lOmgPOQD 1800
20mg PO QD 1800

Order
clarification
will be
received
from
pharmacy

8/98

lovastatin
(Mevacor)
10mgPO QD
20mgPO QD
40mgPO QD
80mg PO QD

simvastatin (Zocor)
5mg PO QD l 800
10mgPOQD 1800
20mgPOQD \800
40mgPOQD 1800

Order
clarification
will be
received
from
pharmacy

8/98

pravastatin
(Pravachol)
10mgPO QD
20mgPO QD
40mgPO QD

simvastatin (Zocor)
5mg PO QD 1800
10mg PO QD 1800
20mg PO QD 1800

Order
clarification
will be
received
from
pharmacy

8/98

..

Pharmacist duty
Order
clarification
will be
received
from
pharmacy

12/99

All orders for atorvastatm (Ltpttor) wtll be dtspensed as wntten.

Antibiotic Use at Lehigh Valley
Hospital: Dispelling the Myths
I am constantly in awe of the information,
or sometimes misinformation that filters
its way down to the Clinical Pharmacy
Office about antibiotic usage here at
Lehigh Valley Hospital. Some of the most
common statements are "We use too much
levofloxacin here" and "Levofloxacin is in
the water". In actuality, levofloxacin IV
isn't even in the top five antibiotics with
regards to number of doses dispensed and
number of patients who received the
antibiotic.
In fiscal year 1999, the Pharmacy
Department dispensed a total of 295,574
doses of antibiotics to 50,792 patients for
a total cost of $1,315,417. The number
one drug in terms of doses dispensed and
patients treated was cefazolin IV. A total
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of 17,695 patients received 55,554 doses of
cefazolin for a total of $57,621. Below is a
table highlighting the top seven antibiotics
dispensed by the pharmacy by number of
doses and number of patients who received
the antibiotic.
Patient
#
Days'
Cases
18,518*
17,695
55,554
Cefazolin IV
6631*
2,777
19,893
Gentamicin IV
4,523
2,725
18,091
Ampicillin IV
5,722
1,641
17,165
Clindamycin IV
8,323
3,107
16,646
Vancomycin IV
5,135
1,757
15,406
Metronidazole IV
3,100
1,184
9,299
Cefazolin/Metronidazole IV
8,265
2,609
Levotloxacin IV
8,265
...
IThts number was calculated by dlvtdmg the number of doses by the number
of times a day the antibiotic is usually administered. The figures for
cefazolin may not reflect actual patient days because the drug is often
times used for surgical prophylaxis. Due to extended interval dosing of
aminoglycosides, the figure for gentamicin may not reflect the actual
patient days
Drug

#Doses

It is true that the pharmacy dispenses a lot

of levofloxacin and when the oral form of
levofloxacin is taken into account this
number increases dramatically. This is in
large part due to the fact that levofloxacin is
a valuable agent. It has a broad spectrum of
activity, has a favorable pharmacokinetic/
pharmacodynamic profile and it is generally
well tolerated. Levofloxacin has utility in a
number of community acquired as well as
hospital-acquired infections. Due to these
properties, it is an attractive choice for
empiric therapy when the offending
organism is not known at the time the
patient presents.
Levofloxacin is used commonly to treat
infections of the urinary tract, upper and
lower respiratory tract and soft tissue and
skin infections. This however, does not
preclude the use of other antibiotics. When
treating urinary tract infections often times a
first generation cephalosporin such as
cefazolin or cephalexin will do. With the
exception of elderly patients,
sulfamethoxazole/ trimethoprim is also
another good option for the treatment of

urinary tract infections. Cefazolin is an
excellent choice for the treatment of most
skin and soft tissue infections. For the
treatment of upper and lower respiratory
tract infections, ceftriaxone plus a
macrolide has been a proven combination
for a number of years. Doxycycline is an
excellent agent for the treatment of upper
and lower respiratory tract infections.
Doxycycline covers the most common
organisms as well as the atypicals.
Due to their utility in a number of
infections, fluoroquinolones will be part of
the antibiotic armamentarium at most
hospitals for many years to come. At the
present time there are seven available
fluoroquinolones on the market. Lehigh
Valley Hospital currently has one on
formulary. Levofloxacin was chosen
because it had cost effective properties that
made it a valuable addition to the Lehigh
Valley Hospital Formulary. As this article
points out, there are many antibiotics from
which to choose here at Lehigh Valley
Hospital. The decision to use or not use a
particular antibiotic ultimately lies with the
prescribing physician and what is
currently available on formulary.
Please keep in mind that it is the
Pharmacy Department's intention to
promote appropriate use of all
medications. Before a medication is added
to formulary the Pharmacy Clinical Office
reviews all available clinical data and
presents its findings to the Therapeutics
Committee where a final decision is made.
While one cannot ignore cost in the
analysis, it is not what drives the final
decision. First and foremost is the quality
of care provided to Lehigh Valley Hospital
patients. Please forward any comments or
questions to Jim Sianis, Pharm.D. in the
Clinical Pharmacy Office at 402-8894.
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January, 2000
Subject: "CARIOLOGY"
Guest Editor: J. Wefel, et al.
Vol. 43, No. 4

News from the Library
OVID/PubMed Training.
********************

MHC.

******

OVID/PubMed TRAINING.

"EMERGENCY CLINICS OF NORTH
AMERICA"
Subject: "ORTHOPEDIC EMERGENCIES"
(Part 1)
Guest Editor: D. Della-Giustina, et al.
Vol. 17, No.4

To schedule a one-on-one OVID (MEDLINE)
training session, call Barbara Iobst in the Health
Sciences Library at 610-402-8408. She can also
instruct you in the use ofPubMed, a free, Webbased MEDLINE service offered by the National
Library of Medicine.

"MEDICAL CLINICS OF NORTH
AMERICA"
Subject: "SCREENING"
Guest Editor: R. Lang, et al.
Vol. 86, No.6.

New Publications.
****************

CC Library.

**********
"DECISION MAKING IN MEDICINE: AN
ALGORITHMIC APPROACH," 2nd edition
Author: H. Greene, II, et al.

Library Hours
CC & 1-78 Library - 8:30 a.m.-5:00p.m.,
Mon.-Fri. (telephone: 610-402-8410)
17 & Chew Library - 9:30 a.m.-3:30p.m.,
Mon.-Fri. (telephone: 610-402-2263)
MHC Library
- 9:00 a.m.-1:00 p.m.,
Mon.-Fri. (telephone: 610-861-2237)

"THE PEDIATRIC CLINICS OF NORTH
AMERICA''
Subject: "AITENTIONDEFICITIHYPERACTIVITY DISORDER"
Guest Editor: A. Morgan
Vol. 46, No. 5

Computer-Based Traininz: (CBT):

17 & Chew Library.

*****************

Computer Based Training (CBT) programs are
available for LVHHN staff. Topics covered by
the CBT programs include: Access 2.0,
PowerPoint 4.0, Windows NT 4, Word 97, Excel
97, Access 97, PowerPoint 97, Lotus 1-2-3
Millenium, WordPerfect 8, PHAMIS LastWord
Inquiry Only commands, and E-mail GUI (check
with your liS analyst to see if you have the GUI
e-mail).

"CLINICAL OBSTETRICS AND
GYNECOLOGY"
Subjects: "CONTROVERSIES IN
OBSTETRICS" I "CONTROVERSIES IN
GYNECOLOGY"
Guest Editors: R. Pitkin and J. Scott
Vol. 42, No. 4
"DENTAL CLINICS OF NORTH
AMERICA"

1
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When liS upgrades your PCs from Windows 311
to Windows NT, your office automation software
will also be upgraded. Prepare for this upgrade
by attending CBT sessions. Any questions about
the NT upgrade should be directed to your liS
analyst.

Areas of Excellence Noted:
(a) Needs assessment--a great job is being done
at focusing and establishing true needs.
(b) Management Procedures--First class
facilities, enviable administrative support
and
financing.

CBT at LVH-CC takes place in Suite 401 ofthe
Cancer Center (the computer training room).
The schedule for L VH-CC is:
1118/2000
12pm- 4pm
1115/2000
l2pm - 4pm
2/112000
8am - l2pm
2/8/2000
12pm - 4pm
2/22/2000
12pm- 4pm
2/29/2000
8am - 12pm
3/7/2000
12pm- 4pm
3/2112000
12pm- 4pm
3/28/2000
8am- 12pm

CEDS is proud to announce that a $50,000
grant has been received from the E. Rhodes and
Leona B. Carpenter Foundation located in
Philadelphia in support of the Network's clinical
pastoral education (CPE) program. CPE brings
theological students and ministers of all faiths
into supervised encounters with people in crisis.

ACCREDITATION COUNCIL FOR
GRADUATE MEDICAL EDUCATION
(ACGME) INSTITUTIONAL REVIEW

CBT at MHC takes place in the computer
training room (in the main hospital building just
off the lobby). The schedule for MHC is:
111112000
8am- 12pm
2/15/2000
8am- 12pm
3/14/2000
8am- 12pm

Institutions sponsoring ACGME-accredited
graduate medical education (GME) programs are
required to undergo a periodic Institutional
Review to monitor compliance with the
ACGME's Institutional Requirements. Lehigh
Valley Hospital's Institutional Review by the
ACGME took place on November 17, 1999.

At each site, twelve slots are available for each
session.

Charles P. Joslyn, Ph.D., Field Representative
for the ACGME, verified Lehigh Valley
Hospital's documentation and implementation of
policies and procedures identified in the
ACGME's Institutional Requirements. Martyn
0. Hotvedt, Ph.D., Director of Educational
Development and Support, and Rosanne M.
Rishko, Residency Program Coordinator, CEDS,
prepared and presented the Institutional Review
Document (IRD) and supporting documentation
to Dr. Joslyn. The action of the Institutional
Review Committee is based to a large extent
upon the information submitted in the IRD. The
results of the Institutional Review will be made
known in April of2000.

To register, please contact Bonnie Schoeneberger
via e-mail or at 610-402-1210 telling her which
session you want to attend. Include a second
choice in case your first is already filled. You
will receive an e-mail confirming your choice
within two business days.
We will be adding more CBT programs to our
curriculum. We will announce any additions via
e-mail. If you have any questions, please contact
Craig Koller at 610-402-1427 or e-mail.

ANNOUNCEMENTS
The Pennsylvania Medical Society has approved
full accreditation of Lehigh Valley Hospital and
Health Network continuing medical education
program, with joint sponsorship privileges, for a
period of four year(s) ending October 2003.

In addition to the Institutional Review Document,
several interviews are required by the ACGME to
verify the accuracy and completeness of the IRD.
Robert J. Laskowski, MD, ChiefMedical·

2
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Officer, met individually with Dr. Joslyn. Next,
Dr. Joslyn met with a group of nine program
directors and physician educators from their
respective residency programs. Included were
Karen Bretz, MD, Jon Bmdjar, DO, John Cox,
MD, Julie Dostal, MD, Gary Nicholas, MD,
Walter Okunski, MD, Richard Snyder, MD,
Stephen Klasko, MD, and Amil Qureshi, DO.

The participation and involvement of the
Graduate Medical Education Committee
(GMEC), Administrators, program directors and
physician educators, residents, and the support
staff contributed to the success of the day.

Any questions, concentl or comment1 011 article1 from CEDS,
please contact Bonnie Scltoeneberger 610-402-1210

Dr. Joslyn then met with twelve resident
representatives who were chosen by the Lehigh
Valley Residency Association from all of the
residency programs. Attending were Scott
Beman, MD, Jeffrey Brown, DO, Johnny Chung,
MD, Jason Clem, MD, Jeffrey Faidley, MD,
James Freeman, DO, Larry Fritchman, MD, Lou
Lukas, MD, Todd Miller, MD, Miles Murphy,
MD, Douglas Semian MD, and Jennifer Thome,
MD.
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